All quotations are from the companies' most recent S-1 filings with links provided.
We are a profitable and growing specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. Our primary target markets are hospital acute care and gastroenterology, which are characterized by relatively concentrated physician prescriber bases. Unlike many emerging pharmaceutical and biotechnology companies, we have established both product development and commercialization capabilities, and believe our organizational structure can be expanded efficiently to accommodate our expected growth. Our management team consists of pharmaceutical industry veterans experienced in business development, clinical and regulatory affairs, and sales and marketing.
Offering: 6.3 million shares at $14.00 - $16.00 per share. Net proceeds of approximately $85.4 million will be used for for acquisitions of product candidates, new products, intellectual property rights to products or companies that complement the company's business.
Lead Underwriters: UBS Investment Bank, Jefferies
Net revenues in 2006 totaled $17.8 million, representing an increase of $7.1 million, or 66.7%, over net revenues in 2005 of $10.7 million... Cost of products sold in 2006 totaled $2.4 million, representing an increase of $1.9 million, or 349.9%, over cost of products sold in 2005 of $533,000... Research and development expense in 2006 totaled $2.2 million, representing an increase of $1.1 million, or 92.9%, over research and development expense in 2005 of $1.2 million.
We are a leading provider of consumer demand management, or CDM, software. Our software enables retailers and consumer products, or CP, companies to define merchandising and marketing strategies based on a scientific understanding of consumer behavior and makes actionable pricing, promotion and other merchandising and marketing recommendations to achieve their revenue, profitability and sales volume objectives. We deliver our applications by means of a software-as-a-service, or SaaS, model, which allows us to capture and analyze the most recent retailer and market-level data and enhance our software rapidly to address our customers’ ever-changing merchandising and marketing needs.
Offering: 6.0 million shares at $10.00 - $12.00 per share. Net proceeds of approximately $58.3 million will be used repay in full the principal and accrued interest on an outstanding loan from Silicon Valley Bank and Gold Hill Venture Lending 03, LP.
Lead Underwriters: Morgan Stanley, Credit Suisse
Fiscal 2007 revenue [$43,485,000] increased approximately $10.9 million, or 34%, over fiscal 2006 revenue [$32,539,000]... Fiscal 2007 cost of revenue [$14,230,000] increased $1.6 million, or 13%, from fiscal 2006 cost of revenue [$12,584,000]... Gross profit increased sequentially in each quarter presented as a result of our expanded customer base and our ability to spread our data center operations and support costs across a larger customer base. Gross margin also increased in each quarter presented through August 31, 2006. Gross margin in each of the third and fourth quarters of fiscal 2007 and the first quarter of fiscal 2008 was less than gross margin in the second quarter of fiscal 2007 due to the inclusion of a partial quarter’s results of TradePoint in our third quarter of fiscal 2007 results and a full quarter’s results of TradePoint in our fourth quarter of fiscal 2007 and first quarter of 2008 results.
We are a leading real estate services company in China based on scope of services, brand recognition and geographic presence. We provide primary real estate agency services, secondary real estate brokerage services as well as real estate consulting and information services. We were ranked as the largest real estate agency and consulting services company in China for three consecutive years from 2004 to 2006 by the China Real Estate Top 10 Committee, as measured by the number of transactions facilitated, transaction value and gross floor area, or GFA, of properties sold, and geographic coverage.
Offering: 14.6 million shares at $11.50 - $13.50 per share. Net proceeds of approximately $129.7 million will be used to fund capital expenditure, to expand our sales and marketing efforts, for general corporate purposes, including funding possible acquisitions of complementary businesses.
Lead Underwriters: Credit Suisse, Merrill Lynch
Our total revenues increased by 44.8% from $38.7 million in 2005 to $56.0 million in 2006... Our cost of revenues decreased by 5.3% from $10.8 million in 2005 to $10.2 million in 2006... we had net income of $18.1 million in 2006, an increase of 62.4% from net income of $11.1 million in 2005.
We are a leading provider of on-demand employment screening solutions. Our customers use our comprehensive screening services in conjunction with our web-based software applications to conduct and manage their employment screening programs efficiently and effectively, make more informed employment decisions, improve workplace safety and mitigate risk. We offer a comprehensive set of background screening services including criminal, motor vehicle and other public records searches, employment, education and professional license verifications and credit checks, as well as drug and health screening services. During 2006, we processed approximately 4.8 million distinct records searches, verifications, checks and screens for our customers.
Offering: 4.4 million shares at $15.00 - $17.00 per share. Net proceeds of approximately $42.5 million will be used for working capital and other general corporate purposes, including the expansion of sales and marketing activities, development of new service offerings and expansion of international operations. Proceeds may also be used for possible, as yet undetermined future acquisitions.
Lead Underwriters: Credit Suisse, Robert Baird
Reimbursed fee revenue increased $1.0 million, or 21.0%, to $5.7 million for the year ended December 31, 2006 as compared to $4.7 million in 2005... Cost of service revenue increased $3.8 million, or 17.2%, to $26.1 million for the year ended December 31, 2006 as compared to $22.3 million in 2005... Sales and marketing expense increased $2.2 million, or 33.6%, to $8.7 million for the year ended December 31, 2006 as compared to $6.5 million in 2005... Because we were profitable in 2006 and expect to remain profitable in 2007, we concluded that it is more likely than not that we will be able to realize substantially all of our net deferred tax assets. Accordingly, we reversed the valuation allowance in 2006. As of December 31, 2006, we had federal and state net operating loss carryforwards of $9.9 million and $0.9 million, respectively. The federal and state net operating losses will begin to expire in 2011 and 2007, respectively.
We are a leading U.S. producer of specialty zinc and zinc-based products with production and/or recycling operations at six facilities in five states. We also own and operate on our premises a 110 megawatt coal-fired power plant that provides us with a cost-competitive source of electricity and allows us to sell approximately one-third of its capacity into the Pennsylvania-New Jersey-Maryland electricity grid. Our products are used in a wide variety of applications, including in the galvanizing of fabricated steel products and as components in rubber tires, alkaline batteries, paint, chemicals and pharmaceuticals. We believe that we are the largest refiner of zinc oxide and Prime Western (“PW”) zinc metal, a grade of zinc containing a minimum of 98.5% zinc, in North America. We believe we are also the largest North American recycler of electric arc furnace (“EAF”) dust, a hazardous waste produced by the steel mini-mill manufacturing process. We, together with our predecessors, have been operating in the zinc industry for more than 150 years.
Offering: 5.6 million shares at $18.00 - $20.00 per share. The company will not receive any of the proceeds from the sale of the shares of common stock offered by this prospectus. Any proceeds from the sale of the shares offered by this prospectus will be received by the selling stockholders.
Lead Underwriters: Friedman Billings, CIBC World Markets
Net sales increased $222.6 million, or 81%, to $496.4 million during fiscal 2006, compared to $273.8 million during fiscal 2005... Cost of sales increased $116.8 million, or 48%, to $359.9 million for fiscal 2006, compared to $243.1 million for fiscal 2005... Selling, general and administrative expenses increased by $21.7 million, or 226%, to $31.3 million during fiscal 2006, compared to $9.6 million during fiscal 2005... Net income increased $51.4 million, or 1,658%, to $54.5 million for fiscal 2006, compared to $3.1 million for fiscal 2005.